ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 88 filers reported holding ERASCA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,462 | -54.0% | 742,100 | -35.6% | 0.00% | -60.0% |
| Q2 2023 | $3,179 | -27.6% | 1,151,700 | -21.0% | 0.01% | -16.7% |
| Q1 2023 | $4,388 | +187.2% | 1,457,690 | +311.1% | 0.01% | +200.0% |
| Q4 2022 | $1,528 | -99.8% | 354,575 | +157.5% | 0.00% | +100.0% |
| Q2 2022 | $767,000 | +321.4% | 137,700 | +549.5% | 0.00% | – |
| Q1 2022 | $182,000 | – | 21,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |